Xiangxue Pharmaceutical (300147) — Capital Reinvestment Ratio
Xiangxue Pharmaceutical (300147) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥75.64 Million) in capital expenditures (CN¥5.74 Million). See 300147 net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Xiangxue Pharmaceutical Capital Reinvestment Ratio (2007–2025)
This chart tracks Xiangxue Pharmaceutical's Capital Reinvestment Ratio across 19 annual periods. Check Xiangxue Pharmaceutical investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Xiangxue Pharmaceutical (2007–2025)
Year-by-year Capital Reinvestment Ratio for Xiangxue Pharmaceutical from 2007 to 2025. For live market cap and broader valuation context, see Xiangxue Pharmaceutical market cap and net worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥139.63 Million | CN¥21.51 Million | ▼ -92.1% |
| 2024 | 1.94x | CN¥18.17 Million | CN¥35.24 Million | ▲ +811.6% |
| 2023 | 0.21x | CN¥263.44 Million | CN¥56.03 Million | ▼ -86.8% |
| 2022 | 1.62x | CN¥227.38 Million | CN¥367.27 Million | ▼ -26.1% |
| 2021 | 2.18x | CN¥257.56 Million | CN¥562.74 Million | ▼ -20.6% |
| 2020 | 2.75x | CN¥257.18 Million | CN¥707.42 Million | ▼ -65.5% |
| 2019 | 7.96x | CN¥83.02 Million | CN¥661.09 Million | ▲ +46.6% |
| 2018 | 5.43x | CN¥91.24 Million | CN¥495.46 Million | ▼ -23.5% |
| 2017 | 7.10x | CN¥109.53 Million | CN¥777.87 Million | ▼ -28.3% |
| 2016 | 9.91x | CN¥198.48 Million | CN¥1.97 Billion | ▲ +471.9% |
| 2015 | 1.73x | CN¥159.89 Million | CN¥276.95 Million | ▲ +17.6% |
| 2014 | 1.47x | CN¥165.58 Million | CN¥243.85 Million | ▲ +51.8% |
| 2013 | 0.97x | CN¥328.37 Million | CN¥318.55 Million | ▼ -72.4% |
| 2012 | 3.52x | CN¥118.91 Million | CN¥418.12 Million | ▼ -55.0% |
| 2011 | 7.81x | CN¥29.55 Million | CN¥230.69 Million | ▲ +524.1% |
| 2010 | 1.25x | CN¥45.47 Million | CN¥56.87 Million | ▲ +9.3% |
| 2009 | 1.14x | CN¥46.19 Million | CN¥52.86 Million | ▼ -53.7% |
| 2008 | 2.47x | CN¥55.72 Million | CN¥137.71 Million | ▲ +135.7% |
| 2007 | 1.05x | CN¥138.02 Million | CN¥144.73 Million | — |